1 Study Coverage
1.1 Peptide Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Peptide Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Parenteral Route of Administration
1.2.3 Mucosal Route of Administration
1.2.4 Oral Route of Administration
1.2.5 Transdermal Route of Administration
1.3 Market by Application
1.3.1 Global Peptide Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Gastrointestinal Disorders
1.3.5 Metabolic Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Peptide Therapy Sales Estimates and Forecasts 2017-2028
2.2 Global Peptide Therapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Peptide Therapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Peptide Therapy Sales by Region
2.4.1 Global Peptide Therapy Sales by Region (2017-2022)
2.4.2 Global Sales Peptide Therapy by Region (2023-2028)
2.5 Global Peptide Therapy Revenue by Region
2.5.1 Global Peptide Therapy Revenue by Region (2017-2022)
2.5.2 Global Peptide Therapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Peptide Therapy Sales by Manufacturers
3.1.1 Global Top Peptide Therapy Manufacturers by Sales (2017-2022)
3.1.2 Global Peptide Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peptide Therapy in 2021
3.2 Global Peptide Therapy Revenue by Manufacturers
3.2.1 Global Peptide Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Peptide Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Peptide Therapy Revenue in 2021
3.3 Global Peptide Therapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Peptide Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Peptide Therapy Sales by Type
4.1.1 Global Peptide Therapy Historical Sales by Type (2017-2022)
4.1.2 Global Peptide Therapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Peptide Therapy Sales Market Share by Type (2017-2028)
4.2 Global Peptide Therapy Revenue by Type
4.2.1 Global Peptide Therapy Historical Revenue by Type (2017-2022)
4.2.2 Global Peptide Therapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Peptide Therapy Revenue Market Share by Type (2017-2028)
4.3 Global Peptide Therapy Price by Type
4.3.1 Global Peptide Therapy Price by Type (2017-2022)
4.3.2 Global Peptide Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Peptide Therapy Sales by Application
5.1.1 Global Peptide Therapy Historical Sales by Application (2017-2022)
5.1.2 Global Peptide Therapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Peptide Therapy Sales Market Share by Application (2017-2028)
5.2 Global Peptide Therapy Revenue by Application
5.2.1 Global Peptide Therapy Historical Revenue by Application (2017-2022)
5.2.2 Global Peptide Therapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Peptide Therapy Revenue Market Share by Application (2017-2028)
5.3 Global Peptide Therapy Price by Application
5.3.1 Global Peptide Therapy Price by Application (2017-2022)
5.3.2 Global Peptide Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Peptide Therapy Market Size by Type
6.1.1 North America Peptide Therapy Sales by Type (2017-2028)
6.1.2 North America Peptide Therapy Revenue by Type (2017-2028)
6.2 North America Peptide Therapy Market Size by Application
6.2.1 North America Peptide Therapy Sales by Application (2017-2028)
6.2.2 North America Peptide Therapy Revenue by Application (2017-2028)
6.3 North America Peptide Therapy Market Size by Country
6.3.1 North America Peptide Therapy Sales by Country (2017-2028)
6.3.2 North America Peptide Therapy Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Peptide Therapy Market Size by Type
7.1.1 Europe Peptide Therapy Sales by Type (2017-2028)
7.1.2 Europe Peptide Therapy Revenue by Type (2017-2028)
7.2 Europe Peptide Therapy Market Size by Application
7.2.1 Europe Peptide Therapy Sales by Application (2017-2028)
7.2.2 Europe Peptide Therapy Revenue by Application (2017-2028)
7.3 Europe Peptide Therapy Market Size by Country
7.3.1 Europe Peptide Therapy Sales by Country (2017-2028)
7.3.2 Europe Peptide Therapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Peptide Therapy Market Size by Type
8.1.1 Asia Pacific Peptide Therapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Peptide Therapy Revenue by Type (2017-2028)
8.2 Asia Pacific Peptide Therapy Market Size by Application
8.2.1 Asia Pacific Peptide Therapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Peptide Therapy Revenue by Application (2017-2028)
8.3 Asia Pacific Peptide Therapy Market Size by Region
8.3.1 Asia Pacific Peptide Therapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Peptide Therapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Peptide Therapy Market Size by Type
9.1.1 Latin America Peptide Therapy Sales by Type (2017-2028)
9.1.2 Latin America Peptide Therapy Revenue by Type (2017-2028)
9.2 Latin America Peptide Therapy Market Size by Application
9.2.1 Latin America Peptide Therapy Sales by Application (2017-2028)
9.2.2 Latin America Peptide Therapy Revenue by Application (2017-2028)
9.3 Latin America Peptide Therapy Market Size by Country
9.3.1 Latin America Peptide Therapy Sales by Country (2017-2028)
9.3.2 Latin America Peptide Therapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Peptide Therapy Market Size by Type
10.1.1 Middle East and Africa Peptide Therapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Peptide Therapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Peptide Therapy Market Size by Application
10.2.1 Middle East and Africa Peptide Therapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Peptide Therapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Peptide Therapy Market Size by Country
10.3.1 Middle East and Africa Peptide Therapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Peptide Therapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Eli Lilly Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Ipsen
11.4.1 Ipsen Corporation Information
11.4.2 Ipsen Overview
11.4.3 Ipsen Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ipsen Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ipsen Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Corporation Information
11.5.2 Novo Nordisk Overview
11.5.3 Novo Nordisk Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novo Nordisk Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novo Nordisk Recent Developments
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Corporation Information
11.6.2 Teva Pharmaceutical Industries Overview
11.6.3 Teva Pharmaceutical Industries Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Industries Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Industries Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Corporation Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Abbott Laboratories Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 J & J
11.9.1 J & J Corporation Information
11.9.2 J & J Overview
11.9.3 J & J Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 J & J Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 J & J Recent Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Overview
11.10.3 Novartis Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Takeda
11.11.1 Takeda Corporation Information
11.11.2 Takeda Overview
11.11.3 Takeda Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Takeda Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Takeda Recent Developments
11.12 Ferring
11.12.1 Ferring Corporation Information
11.12.2 Ferring Overview
11.12.3 Ferring Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Ferring Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ferring Recent Developments
11.13 AbbVie
11.13.1 AbbVie Corporation Information
11.13.2 AbbVie Overview
11.13.3 AbbVie Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 AbbVie Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 AbbVie Recent Developments
11.14 Heinis
11.14.1 Heinis Corporation Information
11.14.2 Heinis Overview
11.14.3 Heinis Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Heinis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Heinis Recent Developments
11.15 Hemmo
11.15.1 Hemmo Corporation Information
11.15.2 Hemmo Overview
11.15.3 Hemmo Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Hemmo Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Hemmo Recent Developments
11.16 Emcure Pharmaceutical
11.16.1 Emcure Pharmaceutical Corporation Information
11.16.2 Emcure Pharmaceutical Overview
11.16.3 Emcure Pharmaceutical Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Emcure Pharmaceutical Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Emcure Pharmaceutical Recent Developments
11.17 Cipla
11.17.1 Cipla Corporation Information
11.17.2 Cipla Overview
11.17.3 Cipla Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Cipla Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Cipla Recent Developments
11.18 Gland Pharma
11.18.1 Gland Pharma Corporation Information
11.18.2 Gland Pharma Overview
11.18.3 Gland Pharma Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Gland Pharma Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Gland Pharma Recent Developments
11.19 Troikaa Pharmaceuticals
11.19.1 Troikaa Pharmaceuticals Corporation Information
11.19.2 Troikaa Pharmaceuticals Overview
11.19.3 Troikaa Pharmaceuticals Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Troikaa Pharmaceuticals Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Troikaa Pharmaceuticals Recent Developments
11.20 Biological E
11.20.1 Biological E Corporation Information
11.20.2 Biological E Overview
11.20.3 Biological E Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Biological E Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Biological E Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Peptide Therapy Industry Chain Analysis
12.2 Peptide Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peptide Therapy Production Mode & Process
12.4 Peptide Therapy Sales and Marketing
12.4.1 Peptide Therapy Sales Channels
12.4.2 Peptide Therapy Distributors
12.5 Peptide Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Peptide Therapy Industry Trends
13.2 Peptide Therapy Market Drivers
13.3 Peptide Therapy Market Challenges
13.4 Peptide Therapy Market Restraints
14 Key Findings in The Global Peptide Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer